The quality of life of frequently vs. infrequently screened HPV vaccinated women.
Cervical cancer screening
HPV
HPV vaccination
Human papillomavirus
Quality of life
Journal
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257
Informations de publication
Date de publication:
18 Jan 2024
18 Jan 2024
Historique:
accepted:
27
11
2023
medline:
19
1
2024
pubmed:
19
1
2024
entrez:
18
1
2024
Statut:
aheadofprint
Résumé
Cervical lesions caused by human papillomavirus (HPV) are related to decreased quality of life (QoL) of women. Also, cervical cancer (CC) screening can cause psychological adverse effects. It has been assumed that by decreasing the HPV-related disease burden, HPV vaccinations would increase the QoL. This study compares the effect of CC screening on QoL of HPV vaccinated women in two different screening protocols. A total of 753 HPV16/18 vaccinated women were randomized to frequent (22/25/28 years of age) and infrequent (28 years of age) CC screening arms. QoL questionnaires (EQ VAS, RAND 36, amended CECA 10) were sent at the age of 28. Median EQ VAS scores were 80 (Q There was no significant difference in the QoL of HPV vaccinated women between the two CC screening arms. Women were mostly satisfied with the screening experience despite the screening frequency. This information is important for the future screening program planning as we need to reach the best possible balance with screening benefits and harms. NCT02149030, date of registration 29/5/2014.
Identifiants
pubmed: 38238599
doi: 10.1007/s11136-023-03575-y
pii: 10.1007/s11136-023-03575-y
doi:
Banques de données
ClinicalTrials.gov
['NCT02149030']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Tampere University Hospital Support Foundation
ID : MK371
Organisme : Suomen Lääketieteen Säätiö
ID : 5525
Informations de copyright
© 2024. The Author(s).
Références
Smith, J. S., Lindsay, L., Hoots, B., Keys, J., Franceschi, S., Winer, R., & Clifford, G. M. (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. International Journal of Cancer, 121(3), 621–632. https://doi.org/10.1002/ijc.22527
doi: 10.1002/ijc.22527
pubmed: 17405118
Trottier, H., & Franco, E. L. (2006). The epidemiology of genital human papillomavirus infection. Vaccine, 24, S4–S15. https://doi.org/10.1016/j.vaccine.2005.09.054
doi: 10.1016/j.vaccine.2005.09.054
Markowitz, L. E., & Schiller, J. T. (2021). Human papillomavirus vaccines. The Journal of Infectious Diseases., 224(Supplement_4), S367–S378. https://doi.org/10.1093/infdis/jiaa621
doi: 10.1093/infdis/jiaa621
pubmed: 34590141
pmcid: 8577198
Arbyn, M., & Xu, L. (2018). Efficacy and safety of prophylactic HPV vaccines. A cochrane review of randomized trials. Expert Review of Vaccines, 17(12), 1085–1091. https://doi.org/10.1080/14760584.2018.1548282
doi: 10.1080/14760584.2018.1548282
pubmed: 30495978
Lehtinen, M., Paavonen, J., Wheeler, C. M., Jaisamrarn, U., Garland, S. M., Castellsagué, X., & Dubin, G. (2012). Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. The Lancet Oncology, 13(1), 89–99. https://doi.org/10.1016/S1470-2045(11)70286-8
doi: 10.1016/S1470-2045(11)70286-8
pubmed: 22075171
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. https://doi.org/10.3322/caac.21660
doi: 10.3322/caac.21660
pubmed: 33538338
Wang, S.-M., Shi, J.-F., Kang, D.-J., Song, P., & Qiao, Y.-L. (2011). Impact of human papillomavirus-related lesions on quality of life: A multicenter hospital-based study of women in Mainland China. International Journal of Gynecologic Cancer, 21(1), 182–188. https://doi.org/10.1097/IGC.0b013e3181ffbed8
doi: 10.1097/IGC.0b013e3181ffbed8
Woodhall, S., Eriksson, T., Nykänen, A.-M., Huhtala, H., Rissanen, P., Apter, D., & Lehtinen, M. (2011). Impact of HPV vaccination on young women’s quality of life – a five year follow-up study. The European Journal of Contraception & Reproductive Health Care, 16(1), 3–8. https://doi.org/10.3109/13625187.2010.536921
doi: 10.3109/13625187.2010.536921
Clarke, P., Ebel, C., Catotti, D. N., & Stewart, S. (1996). The psychosocial impact of human papillomavirus infection: Implications for health care providers. International journal of STD & AIDS, 7(3), 197–200. https://doi.org/10.1258/0956462961917618
doi: 10.1258/0956462961917618
Jentschke, M., Lehmann, R., Drews, N., Hansel, A., Schmitz, M., & Hillemanns, P. (2020). Psychological distress in cervical cancer screening: results from a German online survey. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-020-05661-9
doi: 10.1007/s00404-020-05661-9
pubmed: 32594298
pmcid: 7447652
McBride, E., Marlow, L. A. V., Forster, A. S., Ridout, D., Kitchener, H., Patnick, J., & Waller, J. (2020). Anxiety and distress following receipt of results from routine HPV primary testing in cervical screening: The psychological impact of primary screening (PIPS) study. International Journal of Cancer. https://doi.org/10.1002/ijc.32540
doi: 10.1002/ijc.32540
pubmed: 31800093
Sharp, L., Cotton, S., Gray, N., Avis, M., Russell, I., Walker, L., & Little, J. (2011). Long-term psychosocial impact of alternative management policies in women with low-grade abnormal cervical cytology referred for colposcopy: A randomised controlled trial. British Journal of Cancer. https://doi.org/10.1038/sj.bjc.6606042
doi: 10.1038/sj.bjc.6606042
pubmed: 21326245
pmcid: 3049597
Gray, N. M., Sharp, L., Cotton, S. C., Masson, L. F., Little, J., Walker, L. G., & Woolley, C. M. (2006). Psychological effects of a low-grade abnormal cervical smear test result: Anxiety and associated factors. British Journal of Cancer. https://doi.org/10.1038/sj.bjc.6603086
doi: 10.1038/sj.bjc.6603086
pubmed: 16832415
pmcid: 2360658
Ideström, M., Milsom, I., & Andersson-Ellström, A. (2003). Women’s experience of coping with a positive Pap smear: A register-based study of women with two consecutive Pap smears reported as CIN 1. Acta Obstetricia et Gynecologica Scandinavica, 82(8), 756–761. https://doi.org/10.1080/j.1600-0412.2003.00165.x
doi: 10.1080/j.1600-0412.2003.00165.x
pubmed: 12848648
Sharp, L., Cotton, S. C., Cruickshank, M. E., Gray, N. M., Neal, K., Rothnie, K., & Wells, M. (2015). Long-term worries after colposcopy: Which women are at increased risk? Women’s Health Issues. https://doi.org/10.1016/j.whi.2015.04.002
doi: 10.1016/j.whi.2015.04.002
pubmed: 26189936
Inna, N., Phianmongkhol, Y., & Charoenkwan, K. (2010). Sexual function after loop electrosurgical excision procedure for cervical dysplasia. Journal of Sexual Medicine. https://doi.org/10.1111/j.1743-6109.2009.01633.x
doi: 10.1111/j.1743-6109.2009.01633.x
pubmed: 19968775
Kyrgiou, M., Athanasiou, A., Paraskevaidi, M., Mitra, A., Kalliala, I., Martin-Hirsch, P., & Paraskevaidis, E. (2016). Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: Systematic review and meta-analysis. BMJ (Online). https://doi.org/10.1136/bmj.i3633
doi: 10.1136/bmj.i3633
pubmed: 27469988
Popescu, S. D., Boiangiu, A. G., Sima, R.-M., Bilteanu, L., Vladareanu, S., & Vladareanu, R. (2022). Maternal HPV infection and the estimated risks for adverse pregnancy outcomes—a systematic review. Diagnostics, 12(6), 1471. https://doi.org/10.3390/diagnostics12061471
doi: 10.3390/diagnostics12061471
pubmed: 35741280
pmcid: 9221727
Costa, D. S. J., Mercieca-Bebber, R., Rutherford, C., Tait, M.-A., & King, M. T. (2021). How is quality of life defined and assessed in published research? Quality of Life Research, 30(8), 2109–2121. https://doi.org/10.1007/s11136-021-02826-0
doi: 10.1007/s11136-021-02826-0
pubmed: 33792834
Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993). Measuring health-related quality of life. Annals of internal medicine, 118(8), 622–629. https://doi.org/10.7326/0003-4819-118-8-199304150-00009
doi: 10.7326/0003-4819-118-8-199304150-00009
pubmed: 8452328
Louvanto, K., Eriksson, T., Gray, P., Apter, D., Baussano, I., Bly, A., & Lehtinen, M. (2020). Baseline findings and safety of infrequent vs frequent screening of human papillomavirus vaccinated women. International Journal of Cancer, 147(2), 440–447. https://doi.org/10.1002/ijc.32802
doi: 10.1002/ijc.32802
pubmed: 31749143
Lehtinen, M., Apter, D., Eriksson, T., Harjula, K., Hokkanen, M., Natunen, K., & Struyf, F. (2021). Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland. Cancer Medicine, 10(21), 7759–7771. https://doi.org/10.1002/cam4.4299
doi: 10.1002/cam4.4299
pubmed: 34581025
pmcid: 8559511
The EuroQol Group. (1990). EuroQol - a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208. https://doi.org/10.1016/0168-8510(90)90421-9
doi: 10.1016/0168-8510(90)90421-9
Aalto, A.-M., Aro, A. R., & Teperi, J. (1999). Rand-36 terveyteen liittyvän elämänlaadun mittarina : Mittarin luotettavuus ja suomalaiset väestöarvot.
Badia, X., Colombo, J. A., Lara, N., Llorens, M. A., Olmos, L., Los de Terreros, M. S., & Vilata, J. J. (2005). Combination of qualitative and quantitative methods for developing a new health related quality of life measure for patients with anogenital warts. Health and Quality of Life Outcomes, 3(1), 24. https://doi.org/10.1186/1477-7525-3-24
doi: 10.1186/1477-7525-3-24
pubmed: 15817127
pmcid: 1087499
Vilata, J. J., Varela, J. A., Olmos, L., Colombo, J. A., Llorens, M. A., De Los, S., Terreros, M., & Badía, X. (2008). Validation and clinical use of the CECA, a disease-specific quality of life questionnaire for patients with anogenital condylomata acuminata. Acta dermato-venereologica, 88(3), 257–262. https://doi.org/10.2340/00015555-0422
doi: 10.2340/00015555-0422
pubmed: 18480925
Paradisi, A., Capizzi, R., Ricci, F., di Pietro, C., Abeni, D., & Tabolli, S. (2013). Quality of life in patients with anogenital warts. European Journal of Dermatology, 23(6), 837–842. https://doi.org/10.1684/ejd.2013.2171
doi: 10.1684/ejd.2013.2171
pubmed: 24192222
Maggino, T., Casadei, D., Panontin, E., Fadda, E., Zampieri, M. C., Donà, M. A., & Altoè, G. (2007). Impact of an HPV diagnosis on the quality of life in young women. Gynecologic Oncology, 107(1), S175–S179. https://doi.org/10.1016/j.ygyno.2007.07.013
doi: 10.1016/j.ygyno.2007.07.013
pubmed: 17825395
Pereira-Caldeira, N. M. V., Góes, F. G. B., Almeida-Cruz, M. C. M., Caliari de, J. S., Pereira-Ávila de, F. M. V., & Gir, E. (2020). Quality of life for women with human papillomavirus-induced lesions. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics, 42(04), 211–217. https://doi.org/10.1055/s-0040-1709192
doi: 10.1055/s-0040-1709192
Nagele, E., Reich, O., Greimel, E., Dorfer, M., Haas, J., & Trutnovsky, G. (2016). Sexual activity, psychosexual distress, and fear of progression in women with human papillomavirus-related premalignant genital lesions. The Journal of Sexual Medicine, 13(2), 253–259. https://doi.org/10.1016/j.jsxm.2015.12.012
doi: 10.1016/j.jsxm.2015.12.012
pubmed: 26782607
Ireland, J. A., Reid, M., Powell, R., & Petrie, K. J. (2005). The role of illness perceptions: Psychological distress and treatment-seeking delay in patients with genital warts. International Journal of STD & AIDS, 16(10), 667–670. https://doi.org/10.1258/095646205774357334
doi: 10.1258/095646205774357334
Eriksson, T., Torvinen, S., Woodhall, S. C., Lehtinen, M., Apter, D., Harjula, K., & Lehtinen, M. (2013). Impact of HPV16/18 vaccination on quality of life: A pilot study. The European Journal of Contraception & Reproductive Health Care, 18(5), 364–371. https://doi.org/10.3109/13625187.2013.801953
doi: 10.3109/13625187.2013.801953
Hsu, Y.-Y., Wang, W.-M., Fetzer, S. J., Cheng, Y.-M., & Hsu, K.-F. (2018). Longitudinal psychosocial adjustment of women to human papillomavirus infection. Journal of Advanced Nursing, 74(11), 2523–2532. https://doi.org/10.1111/jan.13725
doi: 10.1111/jan.13725
pubmed: 29845650
Liddon, N. C., Leichliter, J. S., & Markowitz, L. E. (2012). Human Papillomavirus Vaccine and Sexual Behavior Among Adolescent and Young Women. American Journal of Preventive Medicine, 42(1), 44–52. https://doi.org/10.1016/j.amepre.2011.09.024
doi: 10.1016/j.amepre.2011.09.024
pubmed: 22176845
Anastasiou, E., McCarthy, K. J., Gollub, E. L., Ralph, L., van de Wijgert, J. H. H. M., & Jones, H. E. (2022). The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: A systematic review. Contraception, 107, 1–9. https://doi.org/10.1016/j.contraception.2021.10.018
doi: 10.1016/j.contraception.2021.10.018
pubmed: 34752778
Asthana, S., Busa, V., & Labani, S. (2020). Oral contraceptives use and risk of cervical cancer—a systematic review & meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology, 247, 163–175. https://doi.org/10.1016/j.ejogrb.2020.02.014
doi: 10.1016/j.ejogrb.2020.02.014